CN116637130A - Preparation method of ginkgo leaf extract - Google Patents
Preparation method of ginkgo leaf extract Download PDFInfo
- Publication number
- CN116637130A CN116637130A CN202310619853.2A CN202310619853A CN116637130A CN 116637130 A CN116637130 A CN 116637130A CN 202310619853 A CN202310619853 A CN 202310619853A CN 116637130 A CN116637130 A CN 116637130A
- Authority
- CN
- China
- Prior art keywords
- leaf extract
- ginkgo leaf
- concentrated solution
- ethanol water
- concentrating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000009429 Ginkgo biloba extract Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims abstract description 53
- 238000000605 extraction Methods 0.000 claims abstract description 48
- 239000000047 product Substances 0.000 claims abstract description 38
- 238000010992 reflux Methods 0.000 claims abstract description 32
- 241000218628 Ginkgo Species 0.000 claims abstract description 28
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 28
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 27
- 238000001179 sorption measurement Methods 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 238000002156 mixing Methods 0.000 claims abstract description 19
- 238000001035 drying Methods 0.000 claims abstract description 16
- 239000011347 resin Substances 0.000 claims abstract description 16
- 229920005989 resin Polymers 0.000 claims abstract description 16
- 239000000706 filtrate Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 13
- 238000010828 elution Methods 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 239000012535 impurity Substances 0.000 claims abstract description 11
- 238000000227 grinding Methods 0.000 claims abstract description 10
- 239000003463 adsorbent Substances 0.000 claims abstract description 4
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 92
- 239000003480 eluent Substances 0.000 claims description 19
- 241000228245 Aspergillus niger Species 0.000 claims description 17
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 17
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 17
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 17
- 241000894006 Bacteria Species 0.000 claims description 14
- 239000002054 inoculum Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 2
- -1 terpene lactone Chemical class 0.000 abstract description 9
- XUDNWQSXPROHLK-OACYRQNASA-N 2-phenyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC=CC=2)OC2=CC=CC=C2C1=O XUDNWQSXPROHLK-OACYRQNASA-N 0.000 abstract description 8
- 235000007586 terpenes Nutrition 0.000 abstract description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 2
- 239000000654 additive Substances 0.000 abstract description 2
- 230000000996 additive effect Effects 0.000 abstract description 2
- 229930184727 ginkgolide Natural products 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract 1
- 238000011068 loading method Methods 0.000 abstract 1
- 239000002068 microbial inoculum Substances 0.000 description 24
- SQOJOAFXDQDRGF-WJHVHIKBSA-N ginkgolide B Natural products O=C1[C@@H](C)[C@@]2(O)[C@@H]([C@H](O)[C@]34[C@@H]5OC(=O)[C@]23O[C@H]2OC(=O)[C@H](O)[C@@]42[C@H](C(C)(C)C)C5)O1 SQOJOAFXDQDRGF-WJHVHIKBSA-N 0.000 description 14
- AMOGMTLMADGEOQ-FNZROXQESA-N Ginkgolide C Chemical compound O([C@H]1O2)C(=O)[C@H](O)C31[C@]14[C@@H](O)[C@@H]5OC(=O)[C@@H](C)[C@]5(O)[C@@]12C(=O)O[C@@H]4[C@@H](O)[C@H]3C(C)(C)C AMOGMTLMADGEOQ-FNZROXQESA-N 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- FPUXKXIZEIDQKW-MFJLLLFKSA-N ginkgolide A Natural products O=C1[C@H](C)[C@@]2(O)[C@@H](O1)C[C@]13[C@@H]4OC(=O)[C@]21O[C@@H]1OC(=O)[C@H](O)[C@]31[C@@H](C(C)(C)C)C4 FPUXKXIZEIDQKW-MFJLLLFKSA-N 0.000 description 7
- AMOGMTLMADGEOQ-DPFZUGDXSA-N ginkgolide C Natural products O=C1[C@@H](C)[C@]2(O)[C@H]([C@H](O)[C@@]34[C@H]5[C@H](O)[C@@H](C(C)(C)C)[C@]63[C@H](O)C(=O)O[C@H]6O[C@@]24C(=O)O5)O1 AMOGMTLMADGEOQ-DPFZUGDXSA-N 0.000 description 7
- FPUXKXIZEIDQKW-VKMVSBOZSA-N ginkgolide-a Chemical compound O[C@H]([C@]12[C@H](C(C)(C)C)C[C@H]3OC4=O)C(=O)O[C@H]2O[C@]24[C@@]13C[C@@H]1OC(=O)[C@@H](C)[C@]21O FPUXKXIZEIDQKW-VKMVSBOZSA-N 0.000 description 7
- SQOJOAFXDQDRGF-MMQTXUMRSA-N ginkgolide-b Chemical compound O[C@H]([C@]12[C@H](C(C)(C)C)C[C@H]3OC4=O)C(=O)O[C@H]2O[C@]24[C@@]13[C@@H](O)[C@@H]1OC(=O)[C@@H](C)[C@]21O SQOJOAFXDQDRGF-MMQTXUMRSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 5
- 241000245050 Menispermum Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- ORQIZUYAGXZVPI-LBPRGKRZSA-N (5s)-2-methyl-5-[5-(2-methylpropyl)furan-3-yl]cyclohex-2-en-1-one Chemical compound O1C(CC(C)C)=CC([C@@H]2CC(=O)C(C)=CC2)=C1 ORQIZUYAGXZVPI-LBPRGKRZSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- SQFSKOYWJBQGKQ-UHFFFAOYSA-N kaempferide Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- ZYURHZPYMFLWSH-UHFFFAOYSA-N octacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC ZYURHZPYMFLWSH-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- MBDOYVRWFFCFHM-UHFFFAOYSA-N 2-hexenal Chemical compound CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229930063422 Bilobalide A Natural products 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000086550 Dinosauria Species 0.000 description 1
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 1
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 238000001276 Kolmogorov–Smirnov test Methods 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 1
- ORQIZUYAGXZVPI-UHFFFAOYSA-N bilobanone Natural products O1C(CC(C)C)=CC(C2CC(=O)C(C)=CC2)=C1 ORQIZUYAGXZVPI-UHFFFAOYSA-N 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- HUOOMAOYXQFIDQ-UHFFFAOYSA-N isoginkgetin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)OC)=C2O1 HUOOMAOYXQFIDQ-UHFFFAOYSA-N 0.000 description 1
- CGPVRBMMGYBFAC-UHFFFAOYSA-N isoginkgetin Natural products COc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4OC)C5=CC(=O)c6c(O)cc(O)cc6O5 CGPVRBMMGYBFAC-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010331 tianhuang Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method of ginkgo leaf extract. The method comprises the following steps of: 1) Sun drying folium Ginkgo, grinding into powder, mixing with rhizoma Menispermi, adding fermenting agent, and fermenting for 3-10 days to obtain fermented product; 2) Putting the fermented product into an extraction tank, and carrying out hot reflux extraction by using an ethanol water solution; 3) Dissolving the concentrated solution with water, loading into macroporous adsorbent resin column for adsorption, performing gradient elution, collecting 40-60% ethanol water eluate, and concentrating to obtain concentrated solution; 4) Adding ethanol water solution into the concentrated solution, refluxing for dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate, and drying to obtain the final product of ginkgo leaf extract. The ginkgo leaf extract prepared by the invention has higher content of total flavonol glycoside, total terpene lactone and ginkgolide, can be used as an additive of health products, and can also be directly used as a medicament for treating hyperlipidemia and hypertension.
Description
Technical Field
The invention belongs to the technical field of extraction of plant medicinal components, and particularly relates to a preparation method of a ginkgo leaf extract.
Background
Ginkgo leaf is a plant with high medicinal value, ginkgo tree is an ancient tree species, and is a magic medical tree, and ginkgo is one of the most flourishing plants when dwarf dinosaur masters the earth more than 2 hundred million for 5 thousand years. The folium Ginkgo contains flavonoids such as ginkgetin, isoginkgetin, demethylginkgetin, rutin, kaempferide-3-rhamnose glucoside, kaempferide, quercetin, isorhamnetin, etc.; further comprises bitter component ginkgolide A, B, C and bilobalide A; the acid component is toxic octaenoic acid, D-glycosyl acid, ginkgolic acid, bilobanone, octacosane, octacosanol, alpha-hexenal, beta-sitosterol, stigmasterol, vitamins, etc., and contains catechin and epicatechin.
The ginkgo leaf has the effects of astringing lung, relieving asthma, promoting blood circulation to remove blood stasis and relieving pain. Is used for treating cough and asthma due to lung deficiency; coronary heart disease, angina pectoris, hyperlipidemia, anticoagulation, and has certain probability of improving memory. The ginkgo leaf can promote blood circulation and prevent cardiovascular diseases, but other medicaments for treating cardiovascular diseases cannot be taken at the same time, and the ginkgo extract is concentrated granules, has strong free radical removal and antioxidation effects, and the yellow glycoside, amino acid and amino acid in the ginkgo leaf synthesize collagen components to beautify human bodies, inhibit melanin growth and maintain skin luster and elasticity.
The extraction of active ingredients from ginkgo has been reported more. Patent 201210353451.4 discloses a preparation method of ginkgo leaf extract. The method comprises the following steps: step 1) putting ginkgo leaves into an extraction tank, carrying out hot reflux extraction by using an ethanol aqueous solution, combining the extracting solutions, and concentrating to obtain a concentrate A with the density of 0.7-1.2 g/ml; step 2) dissolving the concentrate A with water, then putting the dissolved concentrate A into a DM130, AB-8, DM131 or D318 macroporous adsorption resin column for full adsorption, sequentially carrying out gradient elution by using ethanol water solution with volume fractions of 0%,10-30% and 40-80%, collecting 40-80% ethanol water eluent, and concentrating to obtain a concentrate B; dissolving the concentrate B with ethanol water solution, adding into D101, HPD100, LKY or DM2 macroporous adsorbent resin column, adsorbing thoroughly, eluting with 40-80% ethanol water solution, collecting eluate, concentrating under reduced pressure to density of 0.7-1.2g/ml to obtain concentrate C; and 3) adding ethanol water solution into the concentrate C for reflux dissolution, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate, and drying to obtain the finished ginkgo leaf extract product. The ginkgo active ingredient prepared by the method has low total flavonol glycoside content, total terpene lactone content and ginkgolide A content, ginkgolide B content and ginkgolide C content, and has no obvious medicinal effect.
Disclosure of Invention
The invention provides a preparation method of ginkgo leaf extract in order to overcome the defects in the prior art.
A preparation method of ginkgo leaf extract comprises the following steps:
(1) Sun drying folium Ginkgo and rhizoma Menispermi, grinding into powder, mixing 300-650 parts by weight of folium Ginkgo powder and 10-30 parts by weight of rhizoma Menispermi powder, adding 3-5 parts by weight of fermentation inoculant, adding 200-500 parts by weight of water, stirring, and fermenting at 25-30deg.C for 3-10 days to obtain fermented product;
(2) Putting the fermented product into an extraction tank, performing hot reflux extraction with ethanol water solution, mixing the extractive solutions, and concentrating to obtain concentrated solution with density of 0.8-1.2 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) by using water, then putting the dissolved concentrated solution into a macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent, 10-30 percent and 40-60 percent, collecting an ethanol water eluent with the volume fraction of 40-60 percent, and concentrating to obtain concentrated solution;
(4) Adding ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate, and drying to obtain the ginkgo leaf extract finished product.
The fermentation inoculant is a lactobacillus plantarum LP4 inoculant and an aspergillus niger T2 inoculant according to the mass ratio of 1:1, mixing mixed bacterial agents; the preservation number of the lactobacillus plantarum LP4 is CGMCC No.14533, and the aspergillus niger isThe preservation number of T2 is CGMCC No.2715; the content of viable bacteria in the fermentation inoculant is 1-9X10 8 cfu/g。
The volume fraction of the ethanol aqueous solution in the step (2) is 60-80%, and the dosage is 5-15 times of the mass of the fermented product.
The times of heat reflux extraction in the step (2) are 1-3 times, each time of extraction is 2-5 hours, and the extraction temperature is 60-80 ℃.
In the step (3), the concentrated solution is dissolved by adopting water with the volume of 3-8 times; concentrating 40-60% ethanol water eluent to 1/3-1/8 of original volume.
The macroporous adsorption resin column is D101, HPD100, LKY, 134 or DM2 macroporous adsorption resin column.
And (3) adding 10-30 times of ethanol water solution into the concentrated solution in the step (4) for reflux dissolution.
Concentrating the filtrate in the step (4) to 1/8-1/15 of the original volume.
The drying is spray drying, freeze drying or vacuum drying.
Compared with the prior art, the invention has the following beneficial effects: the ginkgo leaf extract prepared by the invention has higher content of total flavonol glycoside, total terpene lactone and ginkgolide, can be used as an additive of health products, and can also be directly used as a medicament for treating hyperlipidemia and hypertension.
Detailed Description
The following detailed description of specific embodiments of the invention is, but it should be understood that the invention is not limited to specific embodiments.
The lactobacillus plantarum LP4 adopted in the following examples has the preservation number of CGMCC No.14533 and the Aspergillus niger T2 has the preservation number of CGMCC No.2715, and are purchased from the China general microbiological culture Collection center.
Example 1
A preparation method of ginkgo leaf extract comprises the following steps:
(1) Sun drying folium Ginkgo and rhizoma Menispermi, grinding into powder, mixing 500 parts folium Ginkgo powder and 20 parts rhizoma Menispermi powder, and adding 2 partsAdding 300 parts of water into 2 parts of lactobacillus plantarum LP4 microbial inoculum and 2 parts of aspergillus niger T2 microbial inoculum, uniformly stirring, and fermenting for 6 days at 28 ℃ to obtain a fermented product; the content of viable bacteria in the lactobacillus plantarum LP4 microbial inoculum is 3X10 8 cfu/g; the content of viable bacteria in the Aspergillus niger T2 microbial inoculum is 3X10 8 cfu/g;
(2) Putting the fermented product into an extraction tank, adding an ethanol water solution with the volume fraction of 70% by weight for hot reflux extraction, wherein the times of hot reflux extraction are 2 times, each time of extraction is 3 hours, the extraction temperature is 70 ℃, and mixing the extracting solutions, and concentrating to obtain a concentrated solution with the density of 0.9 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) with 6 times of water, then putting the dissolved concentrated solution into a D101 macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent and 20 percent and 50 percent, collecting an ethanol water eluent with the volume fraction of 50 percent, and concentrating the ethanol water eluent to 1/5 of the original volume to obtain concentrated solution;
(4) Adding 20 times volume of ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate to 1/12 of the original volume, and spray drying to obtain the ginkgo leaf extract finished product.
The total flavonol glycoside content in the finished product is 34.9%, the total terpene lactone content is 18.2%, wherein the ginkgolide A content is 6.8%, the ginkgolide B content is 3.8%, and the ginkgolide C content is 6.2%.
Example 2
A preparation method of ginkgo leaf extract comprises the following steps:
(1) Sun-drying ginkgo leaf and asiatic moonseed rhizome, grinding into powder, uniformly mixing 300 parts of ginkgo leaf powder and 10 parts of asiatic moonseed rhizome powder according to parts by weight, adding 1.5 parts of lactobacillus plantarum LP4 microbial inoculum and 1.5 parts of aspergillus niger T2 microbial inoculum, then adding 200 parts of water, uniformly stirring, and fermenting for 3 days at 25 ℃ to obtain a fermented product; the content of viable bacteria in the lactobacillus plantarum LP4 microbial inoculum is 6X10 8 cfu/g; the content of viable bacteria in the Aspergillus niger T2 microbial inoculum is 6X10 8 cfu/g;
(2) Putting the fermented product into an extraction tank, adding 5 times of ethanol water solution with the volume fraction of 60% for hot reflux extraction, wherein the times of hot reflux extraction are 1 time, each time of extraction is 2 hours, the extraction temperature is 60 ℃, mixing the extracting solutions, and concentrating to obtain concentrated solution with the density of 0.8 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) with 3 times of water, then putting the dissolved concentrated solution into an HPD100 macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent and 10 percent and 40 percent, collecting an ethanol water eluent with the volume fraction of 40 percent, and concentrating the ethanol water eluent to 1/3 of the original volume to obtain concentrated solution;
(4) Adding 10 times volume of ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate to 1/8 of the original volume, and freeze-drying to obtain the ginkgo leaf extract finished product.
The total flavonol glycoside content in the finished product is 33.9%, the total terpene lactone content is 17.6%, wherein the ginkgolide A content is 6.4%, the ginkgolide B content is 3.7%, and the ginkgolide C content is 6.3%.
Example 3
A preparation method of ginkgo leaf extract comprises the following steps:
(1) Sun-drying ginkgo leaf and asiatic moonseed rhizome, grinding into powder, uniformly mixing 650 parts of ginkgo leaf powder and 30 parts of asiatic moonseed rhizome powder according to parts by weight, adding 2.5 parts of lactobacillus plantarum LP4 microbial inoculum and 2.5 parts of aspergillus niger T2 microbial inoculum, then adding 500 parts of water, uniformly stirring, and fermenting for 10 days at the temperature of 30 ℃ to obtain a fermented product; the content of viable bacteria in the lactobacillus plantarum LP4 microbial inoculum is 1X10 8 cfu/g; the content of viable bacteria in the Aspergillus niger T2 microbial inoculum is 1X10 8 cfu/g;
(2) Putting the fermented product into an extraction tank, adding an ethanol water solution with the volume fraction of 80% by weight of 15 times, performing hot reflux extraction for 3 times, extracting for 5 hours each time at the extraction temperature of 80 ℃, combining the extracting solutions, and concentrating to obtain a concentrated solution with the density of 1.2 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) with 8 times of water, then putting the dissolved solution into a LKY macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent and 30 percent and 60 percent, collecting an ethanol water eluent with the volume fraction of 60 percent, and concentrating the eluent to 1/8 of the original volume to obtain concentrated solution;
(4) Adding 30 times volume of ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate to 1/15 of the original volume, and vacuum drying to obtain the ginkgo leaf extract finished product.
The total flavonol glycoside content in the finished product is 36.5%, the total terpene lactone content is 17.8%, wherein the ginkgolide A content is 6.1%, the ginkgolide B content is 3.1%, and the ginkgolide C content is 6.1%.
Comparative example 1
A preparation method of ginkgo leaf extract comprises the following steps:
(1) Sun-drying folium ginkgo and rhizoma Menispermi, grinding into powder, mixing 500 parts of folium ginkgo powder and 20 parts of rhizoma Menispermi powder according to parts by weight, adding 4 parts of lactobacillus plantarum LP4 microbial inoculum, adding 300 parts of water, stirring uniformly, and fermenting at 28 ℃ for 6 days to obtain a fermented product; the content of viable bacteria in the lactobacillus plantarum LP4 microbial inoculum is 3X10 8 cfu/g;
(2) Putting the fermented product into an extraction tank, adding an ethanol water solution with the volume fraction of 70% by weight for hot reflux extraction, wherein the times of hot reflux extraction are 2 times, each time of extraction is 3 hours, the extraction temperature is 70 ℃, and mixing the extracting solutions, and concentrating to obtain a concentrated solution with the density of 0.9 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) with 6 times of water, then putting the dissolved concentrated solution into a D101 macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent and 20 percent and 50 percent, collecting an ethanol water eluent with the volume fraction of 50 percent, and concentrating the ethanol water eluent to 1/5 of the original volume to obtain concentrated solution;
(4) Adding 20 times volume of ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate to 1/12 of the original volume, and spray drying to obtain the ginkgo leaf extract finished product.
The total flavonol glycoside content in the finished product is 28.4%, the total terpene lactone content is 15.2%, wherein the ginkgolide A content is 5.1%, the ginkgolide B content is 3.1%, and the ginkgolide C content is 5.5%.
Comparative example 2
A preparation method of ginkgo leaf extract comprises the following steps:
(1) Sun-drying folium ginkgo and rhizoma Menispermi, grinding into powder, mixing 500 parts of folium ginkgo powder and 20 parts of rhizoma Menispermi powder according to parts by weight, adding 4 parts of Aspergillus niger T2 microbial inoculum, adding 300 parts of water, stirring uniformly, and fermenting at 28deg.C for 6 days to obtain fermented product; the content of viable bacteria in the Aspergillus niger T2 microbial inoculum is 3X10 8 cfu/g;
(2) Putting the fermented product into an extraction tank, adding an ethanol water solution with the volume fraction of 70% by weight for hot reflux extraction, wherein the times of hot reflux extraction are 2 times, each time of extraction is 3 hours, the extraction temperature is 70 ℃, and mixing the extracting solutions, and concentrating to obtain a concentrated solution with the density of 0.9 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) with 6 times of water, then putting the dissolved concentrated solution into a D101 macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent and 20 percent and 50 percent, collecting an ethanol water eluent with the volume fraction of 50 percent, and concentrating the ethanol water eluent to 1/5 of the original volume to obtain concentrated solution;
(4) Adding 20 times volume of ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate to 1/12 of the original volume, and spray drying to obtain the ginkgo leaf extract finished product.
The total flavonol glycoside content in the finished product is 23.6%, the total terpene lactone content is 11.2%, wherein the ginkgolide A content is 4.9%, the ginkgolide B content is 2.3%, and the ginkgolide C content is 4.8%.
Comparative example 3
A preparation method of ginkgo leaf extract comprises the following steps:
(1) Sun drying folium Ginkgo, grinding into powder, mixing 520 parts by weight of folium Ginkgo powder, adding 2 parts of Lactobacillus plantarum LP4 microbial inoculum and 2 parts of Aspergillus niger T2 microbial inoculum, adding 300 parts of water, stirring, and fermenting at 28deg.C for 6 days to obtain the final productTo the ferment; the content of viable bacteria in the lactobacillus plantarum LP4 microbial inoculum is 3X10 8 cfu/g; the content of viable bacteria in the Aspergillus niger T2 microbial inoculum is 3X10 8 cfu/g;
(2) Putting the fermented product into an extraction tank, adding an ethanol water solution with the volume fraction of 70% by weight for hot reflux extraction, wherein the times of hot reflux extraction are 2 times, each time of extraction is 3 hours, the extraction temperature is 70 ℃, and mixing the extracting solutions, and concentrating to obtain a concentrated solution with the density of 0.9 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) with 6 times of water, then putting the dissolved concentrated solution into a D101 macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent and 20 percent and 50 percent, collecting an ethanol water eluent with the volume fraction of 50 percent, and concentrating the ethanol water eluent to 1/5 of the original volume to obtain concentrated solution;
(4) Adding 20 times volume of ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate to 1/12 of the original volume, and spray drying to obtain the ginkgo leaf extract finished product.
Comparative example 4
A preparation method of rhizoma Menispermi extract comprises the following steps:
(1) Sun-drying rhizoma Menispermi, grinding into powder, taking 520 parts of rhizoma Menispermi powder according to parts by weight, adding 2 parts of lactobacillus plantarum LP4 microbial inoculum and 2 parts of Aspergillus niger T2 microbial inoculum, adding 300 parts of water, stirring uniformly, and fermenting at 28 ℃ for 6 days to obtain a fermented product; the content of viable bacteria in the lactobacillus plantarum LP4 microbial inoculum is 3X10 8 cfu/g; the content of viable bacteria in the Aspergillus niger T2 microbial inoculum is 3X10 8 cfu/g;
(2) Putting the fermented product into an extraction tank, adding an ethanol water solution with the volume fraction of 70% by weight for hot reflux extraction, wherein the times of hot reflux extraction are 2 times, each time of extraction is 3 hours, the extraction temperature is 70 ℃, and mixing the extracting solutions, and concentrating to obtain a concentrated solution with the density of 0.9 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) with 6 times of water, then putting the dissolved concentrated solution into a D101 macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent and 20 percent and 50 percent, collecting an ethanol water eluent with the volume fraction of 50 percent, and concentrating the ethanol water eluent to 1/5 of the original volume to obtain concentrated solution;
(4) Adding 20 times volume of ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate to 1/12 of the original volume, and spray drying to obtain rhizoma Menispermi extract product.
Experimental example:
the experimental animals were wintar rats, males, weighing about 200g, SPF grade, purchased from Chengdu experimental animals Inc.; the experimental animal feed adopts high-fat feed (73.8% basal feed, 15% lard, 10% yolk powder, 1% cholesterol and 0.2% sodium cholate) and rat growth maintenance material, which are purchased from the biological technology Co., ltd; yixintong, produced by Hainan Tianhuang pharmaceutical Co., ltd., lot number 1608211.
Modeling and grouping drug delivery: the rats are randomly grouped into groups of 10 animals, and each group is fed with 90mg/kg of the heart tonifying ketone group, and 50mg/kg of the ginkgo leaf extract prepared in the examples 1-3 and the comparative examples 1-4. Each of the other groups except the control group was given a high fat diet, and the control group was given a normal diet. The administration was performed 1 time per day by stomach irrigation, and 60 days after the administration, 10mL/kg purified water was administered by the control group and the model group. Weighing 1 time every 10 days, weighing 1 hour after administration on 60 days, taking the first 10 rats of each group, injecting 300mg/kg chloral hydrate into abdominal cavity for anesthesia, collecting blood from abdominal aorta, separating serum, taking heart, freezing with liquid nitrogen, and transferring to a refrigerator at-80 ℃ for standby.
And (3) index detection: measuring TC, TG, HDL-C, LDL-C content (mmol/L) in serum; SOD activity and MDA content (U/mgprot) in myocardial tissues are measured.
Statistical analysis using SPSS 24.0 software for metering data results(mean Standard deviation) means that data normalization test is performed by using a Kolmogorov-Smirnov test method, and for data conforming to normal distribution, the mean difference between two groups is compared by using a t test, so that the data is P<A difference of 0.05 is statistically significant.
The measurement results are shown in tables 1-2:
TABLE 1
Note that: * Represents p <0.05 compared to the control group; # represents p <0.05 compared to example 1.
TABLE 2
Note that: * Represents p <0.05 compared to the control group; # represents p <0.05 compared to example 1.
The above formulation ratios and the embodiments of the process are merely illustrative of the basic principles and characteristics of the present invention, which are not limited by the implementation of the above processes and ratios, and various modifications and changes can be made in the present invention without departing from the spirit and scope of the present invention. Such variations and modifications are therefore within the scope of the present invention.
Claims (9)
1. A preparation method of ginkgo leaf extract is characterized by comprising the following steps:
(1) Sun drying folium Ginkgo and rhizoma Menispermi, grinding into powder, mixing 300-650 parts by weight of folium Ginkgo powder and 10-30 parts by weight of rhizoma Menispermi powder, adding 3-5 parts by weight of fermentation inoculant, adding 200-500 parts by weight of water, stirring, and fermenting at 25-30deg.C for 3-10 days to obtain fermented product;
(2) Putting the fermented product into an extraction tank, performing hot reflux extraction with ethanol water solution, mixing the extractive solutions, and concentrating to obtain concentrated solution with density of 0.8-1.2 g/ml;
(3) Dissolving the concentrated solution prepared in the step (2) by using water, then putting the dissolved concentrated solution into a macroporous adsorption resin column for adsorption, sequentially carrying out gradient elution by using an ethanol water solution with the volume fraction of 0 percent, 10-30 percent and 40-60 percent, collecting an ethanol water eluent with the volume fraction of 40-60 percent, and concentrating to obtain concentrated solution;
(4) Adding ethanol water solution into the concentrated solution prepared in the step (3), refluxing and dissolving, filtering at normal temperature to remove insoluble impurities, concentrating the filtrate, and drying to obtain the ginkgo leaf extract finished product.
2. The preparation method of the ginkgo leaf extract according to claim 1, wherein the fermentation inoculant is lactobacillus plantarum LP4 inoculant and aspergillus niger T2 inoculant according to the mass ratio of 1:1, mixing mixed bacterial agents; the preservation number of the lactobacillus plantarum LP4 is CGMCC No.14533, and the preservation number of the aspergillus niger T2 is CGMCC No.2715; the content of viable bacteria in the fermentation inoculant is 1-9X10 8 cfu/g。
3. The method for preparing ginkgo leaf extract according to claim 1, wherein the volume fraction of the aqueous ethanol solution in the step (2) is 60-80% and the amount is 5-15 times the mass of the fermented product.
4. The method for preparing ginkgo leaf extract according to claim 1, wherein the number of times of thermal reflux extraction in the step (2) is 1-3, each time for 2-5 hours, and the extraction temperature is 60-80 ℃.
5. The method for preparing ginkgo leaf extract according to claim 1, wherein the concentrated solution in the step (3) is dissolved by 3-8 times of water; concentrating 40-60% ethanol water eluent to 1/3-1/8 of original volume.
6. The method for preparing ginkgo leaf extract according to claim 1, wherein the macroporous adsorbent resin column is D101, HPD100, LKY, 134 or DM2 macroporous adsorbent resin column.
7. The method for preparing ginkgo leaf extract according to claim 1, wherein 10-30 times of volume of ethanol aqueous solution is added to the concentrated solution in the step (4) for reflux dissolution.
8. The method for preparing ginkgo leaf extract according to claim 1, wherein the filtrate in the step (4) is concentrated to 1/8-1/15 of the original volume.
9. The method for preparing ginkgo leaf extract according to claim 1, wherein the drying is spray drying, freeze drying or vacuum drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310619853.2A CN116637130A (en) | 2023-05-30 | 2023-05-30 | Preparation method of ginkgo leaf extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310619853.2A CN116637130A (en) | 2023-05-30 | 2023-05-30 | Preparation method of ginkgo leaf extract |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116637130A true CN116637130A (en) | 2023-08-25 |
Family
ID=87639405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310619853.2A Pending CN116637130A (en) | 2023-05-30 | 2023-05-30 | Preparation method of ginkgo leaf extract |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116637130A (en) |
-
2023
- 2023-05-30 CN CN202310619853.2A patent/CN116637130A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113150867B (en) | Preparation method of ganoderma lucidum extract oil rich in ganoderma lucidum triterpenes | |
KR100813914B1 (en) | The conversion and modification of natural medicines by intestinal probiotics co-fermentation cultures | |
CN104982928B (en) | A kind of japanese yew fruit health care ferment and preparation method thereof | |
CN112999261B (en) | Natto fermented composition capable of relieving arteriosclerosis and preparation method and application thereof | |
CN103462025A (en) | Health food assisting in reducing blood fat and preparation method and application thereof | |
CN107714794B (en) | Russian extract tablet and preparation method thereof | |
CN108618128A (en) | Adjust the composition and its preparation method and application of immunity | |
KR20160059137A (en) | MANUFACTURE OF FERMENTED Alliumhookeri FROM LACTIC ACID BACTERIA AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
CN112515014A (en) | Kudzuvine root polysaccharide sweet zong black tea and preparation method thereof | |
CN110613818A (en) | Walnut, perilla and fish oil capsules for preventing and treating memory decline and insomnia and preparation method thereof | |
CN116637130A (en) | Preparation method of ginkgo leaf extract | |
KR101795261B1 (en) | Medicinal-Herb Composition Comprising Chinese matrimony vine for Treatmenting and Protecting the Insomniac and the Method of Making the Same | |
WO2021142920A1 (en) | Traditional chinese medicine composition for treating lung cancer, and preparation and use thereof | |
CN108567943B (en) | Preparation method of loquat cough-relieving syrup | |
CN107372947B (en) | Tea bag type blood sugar reducing tea and preparation method thereof | |
KR101093006B1 (en) | Method for producing functional health food containing bezoar bovis used microbes and the functional health food produced by the same | |
KR101281226B1 (en) | RedGingsen with lactobacillus coated micro-starch | |
CN113100442B (en) | Royal jelly tortoise turtle peptide chewing tablet and preparation process thereof | |
CN113621673B (en) | Method for fermenting ginseng by composite strain, fermentation product and application | |
CN102599312A (en) | Oligosaccharide Panax notoginseng sweet tea and preparation method thereof | |
CN115282185B (en) | Fermented salvia miltiorrhiza extract containing salvia miltiorrhiza enzymes, and preparation method and application thereof | |
CN116211956B (en) | Composition for regulating intestinal tract and/or improving obesity, preparation method, chewable tablet and application thereof | |
CN115006489B (en) | Fermented rhizoma polygonati extract with blood pressure reducing effect, preparation method and application | |
CN114712481B (en) | Composite plant source polypeptide and preparation method and application thereof | |
CN113785982B (en) | Anti-fatigue and anti-radiation capsule for spaceflight and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |